WE CARE ABOUT THE SCIENCE BEHIND THE SCIENCE

The first and only Life Sciences company dedicated to Ancillary Supply Chain for clinical research
LeadershipDistribution Network

The First to Focus on Clinical Trial Ancillary Supply Chain

Ancillare believes that the science behind the science is paramount to enabling the best clinical research. Applying proven supply chain strategies born from innovative problem solving,  we arm Sponsors of global clinical trials with customized, end-to-end supply plans. This enables developers of new therapies to optimize their supply chains using streamlined processes, extensive global buying power, a vast depot network, and proven teams of clinical, procurement, operations, logistics, and regulatory experts. Ancillare’s industry-shaping model navigates the complexities of the Clinical Trial Ancillary Supply Chain to reduce both the overall cost and cycle time of clinical trials, and greatly improve operational efficiency across all levels of the value chain.

MORE THAN

Ancillary Supply Chains Completed

GREATER THAN

%

Global Sites Covered

AT LEAST

Patients Served

Diversity means better discussions. Better decisions. Better outcomes. For all.

We are proud to be a certified women-owned business by the Women’s Business Enterprise National Council (WBENC).

The top global biopharmaceutical companies trust Ancillare to help them achieve supplier diversity and further their social responsibility initiatives. As a global Tier 1 supplier, we are dedicated to delivering innovative sourcing and procurement solutions.

Looking for ways to strengthen your supplier diversity program? We can help.

Executive Leadership

Our diverse, global staff are led by dedicated, multi-disciplinary professionals.

Dr. Joanne Santomauro

CHIEF EXECUTIVE OFFICER & Founder

Dr. Joanne Santomauro, Chief Executive Officer and Founder of Ancillare, LP, created the Clinical and Ancillary Supply Chain (CTASC) Management industry in 2006. Joanne’s 35 years of supply chain management expertise led the company to launch its market-leading model. Her leadership has resulted in Ancillare’s explosive growth throughout the world.

For more than a decade, Joanne has led her teams in the innovation, development, enhancement, and expansion of the Ancillare CTASC supply chain model, delivered through state-of-the-art technologies and methodologies previously unrealized in the marketplace. The CTASC model embraces the complexities and globalization of the ancillary supply chain and manages the chain with a singular focus. This proven flexible and scalable model ensures a transparent and efficient process for Sponsors and their CROs.

Joanne successfully completed the Committee of 200 Growing Entrepreneurs Program in 2005, the Tuck School of Business Executive Program in 2008, and she is the recipient of the 2011 Enterprising Women of the Year and Marcum’s Innovator of the Year awards. Joanne was a finalist for the EY Entrepreneur Of The Year® 2018 Award in the Greater Philadelphia region. The company was listed in 2012 and 2014 as one of the fastest growing companies in the region. In addition, Ancillare received the 2011 U.S. Department of Commerce Export Achievement Award and the 2014 U.S. Secretary of Commerce Star Award for Excellence in Exports. Joanne serves on the YMWIC Foundation Board, a STEM program dedicated to the advancement of science, technology engineering, and math for middle through high school students. And she holds advanced degrees including a Doctorate in Business from the Temple University Fox School of Business.

Senior Management Team

OUR GLOBAL ANCILLARY SUPPLY CHAIN DISTRIBUTION NETWORK

We have strategically located depots across across North America, Europe, and Asia-Pacific, covering more than 100 countries and delivering to 98% of clinical trial sites.

A HISTORY OF INNOVATION

In 2006, Ancillare took the first steps toward creating a first-of-its kind business: one that is wholly dedicated to the discipline of Clinical Trial Ancillary Supply Chain Management. Today, it is the category leader. Take a look back at the company’s biggest milestones and accomplishments.

}
Present

Present

8 of the Top 10 Global Pharmaceutical, 3 of the Top 5 Global Biotechnology companies, and 2 of the Top 3 Global CROs employ Ancillare’s Clinical Trial Ancillary Supply Chain Management solutions.

Ancillare continues its singular, industry-leading mission as the global standard for Ancillary Supply Chain Management for Phase I-IV clinical research.

}
2018

2018

CEO Joanne Santomauro is recognized as an Ernst & Young Entrepreneur of the Year finalist.

CEO Joanne Santomauro is recognized as a Most Admired CEO honoree by the Philadelphia Business Journal.

}
2017

2017

Ancillare’s MedTech Division is established to service medical device and diagnostic trials.

Ancillare expands the Global Clinical Development Department.

}
2016

2016

Ancillare celebrates its 10th Anniversary.

}
2015

2015

Ancillare’s first and only end-to-end clinical trial ancillary supply chain model is introduced to ensure consistency, accuracy, and cost control throughout the development program lifecycle.

Ancillare establishes Depots in China, Japan, Russia, and Taiwan.

}
2014

2014

Ancillare’s ESTEEM™ (Executing Shipments Through Effective Enrollment Monitoring) model is deployed. Resupply now matches site-specific patient enrollment rates, aligning distribution on demand.

Ancillare establishes Depots in Argentina, Brazil, Israel, Mexico, and Ukraine.

}
2013

2013

The Ancillare Supply Chain Management System (ANSUMS™) is implemented, streamlining the process of ancillary product resupply and offering global visibility and reporting across the entire clinical pipeline.

}
2012

2012

Ancillare Europe established in Milton Keynes, UK to service the EMEA region.

Ancillare establishes Depot in Canada.

}
2011

2011

Ancillare Global Headquarters established in Horsham, PA.

}
2008

2008

The Ancillare Professional Team™ (APT) is formed to provide a dedicated management platform for clinical trial supply chain services for each sponsor organization.

}
2006

2006

Ancillare, LP is founded in North Wales, PA.

Social Responsibility

We are all a vital piece of the global community. We believe in providing long-term value to our clients, employees, partners, and the communities in which we live and work through philanthropic contributions.

Our corporate culture demands that we act responsibly, complying fully with all applicable ethics policies, regulations and regulatory guidelines while ensuring all the work we do — from sourcing to distribution to destruction or reclamation — is conducted in a manner that is responsible to the communities in which we operate.

Further, both individually and in teams, we participate in a variety of activities focused on children, underserved communities, health and animal welfare. Our employees regularly organize and host fundraising activities to raise awareness and funds to support these organizations, which include:

Request More Information About Ancillare

Tell us a little about your project or ancillary supply challenges, and we will set up a consultation with our team.